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Abstract
Background: Clinical trials commonly have a dedicated trial manager and effective trial management is essential to
the successful delivery of high-quality trials. Trial managers have diverse experience and currently there is no
standardised structured career pathway. The UK Trial Managers’ Network (UKTMN) surveyed its members to
understand what is important to them with respect to career development since this would be important in the
development of any initiative intended to develop a skilled workforce.
Methods: We conducted an online survey of UKTMN members, who are trial management professionals, working
on academic-led trials in the UK. Members were asked what they perceive as opportunities and barriers to career
development. Two reminders were sent to facilitate completion of the survey, and responders were offered the
opportunity to enter a prize draw for waived fees at the UKTMN annual meeting. Data were analysed descriptively
by using Stata (version 15.1), and free-text responses were reviewed for themes.
Results: The survey was sent to 819 UKTMN members; 433 responses were received, although 13 were from non-
UKTMN members; thus 420 respondents' data were included in analyses. Respondents were representative of
UKTMN membership; however, more responses were received by trial managers based in registered clinical trials
units (CTUs). The top three opportunities for career development were (i) training, (ii) helping design trials and (iii)
undertaking relevant qualifications. The top three barriers were (i) funding, (ii) few opportunities to get involved in
development activities aside from managing a trial and (iii) unclear organisational career pathway. Almost all
respondents (401/420, 95.4%) considered career development either very or quite important. Although all
respondents had a day-to-day role in managing trials, there was huge disparity between job titles.
(Continued on next page)
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Conclusion: Career development is important to trial managers yet there is a lack of a structured pathway. The
enablers and disablers to career development for trial managers should be clearly considered by the clinical trial
community and, in particular, employers, sponsors and funders in order to develop a highly skilled workforce of trial
managers, who are key to the delivery of trials.
Keywords: Clinical trial, Trial management, Trial manager, Career development, Survey, UKTMN, Project
management
Background
Clinical trials are considered the gold standard for test-
ing health-care interventions in patients. Not only do
clinical trials need to be led by a chief investigator, but
these complex projects require expert project manage-
ment and it is commonplace for trials to appoint a dedi-
cated person to manage the trial. Effective trial
management has been shown to be essential to the suc-
cessful delivery of high-quality trials [1], and the Strat-
egies for Trial Enrolment and Participation Study
(STEPS), which investigated strategies to improve re-
cruitment into randomised trials, showed that the ap-
pointment of a dedicated trial manager was one factor in
trials that recruited more successfully [2]. Indeed, UK
major public funding bodies such as the National Insti-
tute for Health Research (NIHR) recommend the ap-
pointment of a dedicated trial manager and send a
general trial manager job description at the time of pro-
ject activation. Treweek and Littleford acknowledged
that once clinical trial funding was awarded, the most
important members of the team are “not the professors
and investigators but the trial managers” who are key to
delivering the goal [3], and Beaumont et al. recently
wrote that having an “expert” trial manager, who can
overcome operational challenges, is often the difference
between success and failure of a clinical trial [4]. Over
20 years ago, one of the UK’s largest funders of clinical
trials at the time, the Medical Research Council (MRC),
commissioned the development of the Trial Managers’
Network in response to the failure of academic-led trials
to deliver on time and budget and a lack of training
identified for staff who were responsible for managing
clinical trials. The network, now known as the UK Trial
Managers’ Network (UKTMN), aims to facilitate the de-
velopment and support of trial managers across the UK
[5] and has long argued that there is a lack of recogni-
tion of the role of trial manager, particularly at an organ-
isational level, and an absence of a structured career
pathway. Trial managers come from a diverse range of
backgrounds with no recognised career pathway and so
usually learn “on the job” [1], which the authors acknow-
ledge is an important part of career development though
also recognise that this could be enhanced by technical
and theoretical knowledge to underpin it. Recently,
several publications have acknowledged a lack of career
development pathways for trial managers [4, 6, 7], and
Beaumont et al. recognised that whilst some progress
has been made in the development of academic career
pathways in some universities, not all trial managers
may wish to pursue this and therefore alternative path-
ways should be considered. From our own experience
across several organisations and discussions with
UKTMN members, we find that where pathways do
exist, there is disparity across organisations.
The UKTMN Executive Group, responsible for the stra-
tegic direction of the network, surveyed its membership
(over 800 members) to understand what is important to
them with respect to their own career development since
this would be important for any initiative aimed at im-
proving the development and retention of a skilled work-
force. For the purpose of this article, a trial management
professional is someone who has day-to-day responsibility
for the management of operational aspects of an
academic-led clinical trial or other high-quality clinical
study, although the authors acknowledge that there is sig-
nificant disparity between job titles across the UK. For ex-
ample, a trial coordinator in one organisation could have
overall responsibility for a clinical trial whereas in other
organisations the role associated with this job title is a
supportive one. UKTMN members are based in a variety
of organisations, including universities, clinical trials units
(CTUs) and National Health Service (NHS) trusts.
Methods
We conducted an open survey of UKTMN members.
Survey questions included a mixture of quantitative and
free-text responses (Additional file 1). The survey was
built using Jisc Online Surveys©, and prior to circulation
a draft version of the survey was user-tested by six trial
managers, all from a trial management background, in
departments where authors were based. A link was cir-
culated to all members in June 2019 and open for 20 cal-
endar days, and two reminders were circulated during
this time. Survey questions and response categories were
agreed by the authors. Adaptive questioning was used
when required to increase the simplicity of completion,
and participants were able to review and edit their re-
sponses prior to final submission. Completion of the
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survey was voluntary, and consent was assumed by com-
pletion of the survey.
To encourage completion of the survey, all partici-
pants were given the option of providing their email ad-
dress and being entered into a prize draw to have their
delegate fees waived at the UKTMN annual meeting
held later in 2019. Participants’ contact details were not
linked to other survey data when analysed and were
stored in the password-protected online survey. For
questions relating to career development opportunities
that are considered important, participants were asked
to rate each opportunity from 0 to 10 (0 being not im-
portant, 10 being the most important). These data are
presented as mean (standard deviation [SD]) scores.
From a pre-populated list defined by the authors, partici-
pants were also asked to state which issues they per-
ceived as barriers to career development. For both
opportunities and barriers to career development, ana-
lyses were undertaken for all responses and associations
that were felt to potentially influence opinion: length of
time in a trial management role, salary scale (used as a
proxy for level of experience given the known disparity
between job titles across organisations), whether partici-
pants had previously been promoted, whether they were
currently based in a UK Clinical Research Collaboration
(UKCRC)-registered CTU and, for those employed
within an academic setting, whether they were employed
on a professional/managerial or research contract. De-
scriptive analyses were undertaken by using Stata (ver-
sion 15.1), and free-text responses were reviewed for
themes by using NVivo (version 12.1).
Results
The survey was sent to 819 UKTMN members and 433
responses were received. Thirteen responses were re-
ceived by non-members of UKTMN and this was pos-
sibly due to the fact that the survey link was forwarded
by members; their data were not included in analyses
and thus data are presented on 420 participants (Fig. 1).
Limited data are collected at the time of applying for
UKTMN membership; however, some comparisons be-
tween characteristics of UKTMN members and those of
survey respondents could be made: characteristics of
survey respondents reflect that of the overall UKTMN
membership for geographical spread across the UK and
job titles, although there were slightly more responses
from respondents who identified as a senior trial man-
ager (93/420, 22.1%) compared with UKTMN member-
ship (109/819, 13.3%) (Table 1).
There were also a higher number of responses from
staff based in registered CTUs (317/420, 75.5%) com-
pared with UKTMN membership (464/819, 56.7%); 356/
420 (84.8%) of responders were based in universities, the
remaining were based mainly in the NHS, and almost all
respondents were on a non-academic pay scale. Surpris-
ingly, of individuals based in an academic setting (i.e.,
university), only a quarter were on a research-type con-
tract, and the majority were employed on a professional/
administrative/managerial contract. Just under a third of
participants had worked in a trial management role for
between 3 and 5 years, and a further 20% had 6–10 years’
experience; 278/420 (66.2%) participants were funded via
grant or research funding, 41/420 (9.8%) were core-
funded and 77/420 (18.3%) were funded by a combin-
ation of the two. Almost all participants (396/420, 94.3%)
were educated to at least undergraduate-degree level, 111/
420 (26.4%) had a PhD and 138/420 (32.9%) had a masters
or other postgraduate qualification; 176/420 (41.9%) par-
ticipants referred to themselves as a trial manager, and the
other participants had a wide range of job titles. Nearly
one third (114/420) had a salary between £35,000 and £39,
999. Just over half of participants (224/420) answered yes
to the question “Have you ever experienced a promotion/
progression to a more senior role”. For the 196 partici-
pants who had never progressed, the main reason stated
was “no career pathway in my organisation” (66/196,
33.7%), and 62/196 (31.6%) participants stated that they
had “not been in the role long enough for promotion to
be relevant”. For the 66/196 respondents who had not
progressed because there was no career pathway in their
organisation, just under half (30/66, 45.5%) were based in
a registered CTU. For participants who had progressed
(224/420), 29% had done this via a promotional pathway
in the organisation and the remaining 71% had done this
via an application to a new or vacant position outside of
the organisation; 401/420 (95.4%) considered career devel-
opment either ‘very’ or ‘quite’ important.
Opportunities
From a list of 12 potential opportunities considered im-
portant to career development, participants were asked
to rate each one between 0 and 10 (0 being not import-
ant, 10 being the most important) (Table 2).
Fig. 1 Flowchart
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Table 1 Characteristics of survey respondents
Characteristic n = 420 (%) Overall UKTMN
membership
n = 819 (%)
Gender
Female 364 (86.7) Data unavailable
Male 53 (12.6)
Prefer not to say 3 (0.7)
Based in a UKCRC-registered CTU
Yes 317 (75.5) 464 (56.7)
No 103 (24.5) 355 (43.3)
Location of CTU, n = 317
London 49 (15.5) 145 (17.7)
West Midlands 44 (13.9) 87 (10.6)
Scotland 38 (12) 86 (10.5)
Oxfordshire 35 (11) 129 (15.8)
Yorkshire and the Humber 29 (9.2) 66 (8.1)
North West 29 (9.2) 66 (8.1)
South West 22 (6.9) 73 (8.9)
East Midlands 17 (5.4) 41 (5.0)
South East 15 (4.7) 34a (4.2)
Wales 14 (4.4) 28 (3.4)
East of England 14 (4.4) 42 (5.1)
South Central 7 (2.2) 34a (4.2)
Northern Ireland 3 (1.0) 6 (0.7)
North East 1 (0.3) 16 (2.0)
Employment status
Full-time 313 (74.7) Data unavailable
Part-time 106 (25.3)
Missing 1 (0.2)
Organisation type
University 356 (84.8) 729 (89.0)
NHS 60 (14.3) 86 (10.5)
Charity/Not for profit 4 (0.1) 4 (0.5)
NHS grade/pathway, n = 60
Administrative/clerical 35 (58.3) Data unavailable
Managerial 19 (31.7)
Clinical 1 (1.7)
Nursing/Health-care professional 4 (6.7)
Research 1 (1.7)
Academic grade/pathway, n = 356
Professional/Administrative/Managerial/Academic-related 267 (75.1) Data unavailable
Research 67 (18.9)
Not known 20 (5.1)
Academic/Academic-related (research) 2 (0.5)
Length of time in a trial management role
<1 year 32 (7.6) Data unavailable
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Table 1 Characteristics of survey respondents (Continued)
Characteristic n = 420 (%) Overall UKTMN
membership
n = 819 (%)
1–2 years 66 (15.7)
3–5 years 126 (30)
6–10 years 89 (21.2)
>10 years 107 (25.5)
Funding for current position
Grant/research funding 278 (66.2) Data unavailable
Combination of core/grant funding 77 (18.3)
Core-funded 41 (9.8)
Don’t know 22 (5.2)
Institute-funding (based in a charity) 1 (0.2)
No salary – honorary research fellow 1 (0.2)
Highest educational qualification
PhD 111 (26.4) Data unavailable
Masters or other post-graduate qualification 138 (32.9)
Undergraduate degree 147 (35)
A levels or equivalent 16 (3.8)
General Certificates of Secondary Education (GCSEs) or equivalent 6 (1.4)
Vocational qualifications 1 (0.2)
None of the above 1 (0.2)
Current job title
Trial manager 176 (41.9) 380 (46.4)
Senior trial manager/team lead 93 (22.1) 109 (13.3)
Trial coordinator 77 (18.3) 174 (21.2)
Trial administrator/assistant 9 (2.1) 22 (2.7)
Other 65 (15.5) 134 (16.4)
Project manager 11
Operations manager 11
Research assistant/associate/fellow 11
Assistant/associate trial manager 6
Senior trial coordinator 6
Senior research fellow/associate 4
Programme manager 3
Data manager 3
Head of trial management 2
Assistant professor of clinical trials 1
Compliance manager 1
Research facilitator 1
Senior research manager 1
Senior research midwife 1
Trial master file manager 1
Trial director 1
Trial management director 1
Current salary range (full-time equivalent)
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The top three perceived most important opportunities
were (1) to attend relevant training courses (mean 8.3,
SD 1.8), (2) to help in the design of trials (mean 7.7, SD
2.4) and (3) to undertake relevant qualifications applic-
able to trial management (mean 7.5, SD 2.6). The most
important opportunity for almost all groups, irrespective
of possible associations previously described, was “to at-
tend relevant training courses”. The top three opportun-
ities by the characteristics described above are shown in
Table 3. Participants were also asked to state any other
opportunities that they considered important with re-
spect to career development; in total, there were 35 re-
sponses, many of which were covered by the list of
opportunities given, although several responses stated
that they would like the opportunity to develop leader-
ship and line management responsibilities.
Barriers
Participants were asked to select perceived barriers to
career development from a list of nine with the option
of giving additional barriers not included in the list
(Table 4). The top three perceived barriers were “fund-
ing” (256/420, 61%), “few opportunities to get involved
in other activities aside from managing a clinical trial(s)”
(249/420, 59.3%) and “unclear career pathway within the
organisation” (247/420, 58.8%).
The top three barriers to career development, by the char-
acteristics previously described, are shown in Table 5. Partic-
ipants were asked to state any other barriers perceived, not
included in the pre-populated list. These included; (i) fixed
term contracts, (ii) line managers' insistence on the need to
focus on "delivery of trials", (iii) an assumption by the aca-
demic community that academic qualifications are needed
Table 1 Characteristics of survey respondents (Continued)
Characteristic n = 420 (%) Overall UKTMN
membership
n = 819 (%)
<£18,000 1 (0.2)
£18,000–£21,999 1 (0.2)
£22,000–£24,999 8 (1.9)
£25,000–£26,999 17 (4.1)
£27,000–£31,999 70 (16.7)
£32,000–£34,999 65 (15.5)
£35,000–£39,999 114 (27.1)
£40,000–£43,999 67 (16.0)
>£44,000 61 (14.5)
Prefer not to say 16 (3.8)
Ever experienced a promotion/progression to more senior role
Yes 224 (53.3) Data unavailable
No 196 (46.7)
Reason for no experience of promotion/progression, n = 196
No career pathway in my organisation 66 (33.7) Data unavailable
Not in role long enough for this to be relevant 62 (31.6)
Never been given the opportunity 50 (25.5)
Not wanted to 18 (9.2)
If promoted/progressed, how this happened, n = 224
Via application to new/vacant position outside your organisation 159 (71) Data unavailable
Via a promotional pathway in your organisation 65 (29)
Importance of career development
Very important 276 (65.7) Data unavailable
Quite important 125 (29.8)
Not very important 18 (4.3)
Not important at all 1 (0.2)
Abbreviations: CTU clinical trials unit, NHS National Health Service, UKCRC UK Clinical Research Collaboration, UKTMN UK Trial Managers’ Network
aSouth East and South Central are counted together at time of UKTMN membership and therefore cannot be reported separately in this table; they are shown
twice for transparency
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to progress when experience is often just as valuable and
(iv) the job title "trial manager" can imply an administrative
rather than professional to many.
Participants were asked to report how well supported
they felt, with respect to professional development, by
their line manager, department/unit (within the organisa-
tion) and the organisation itself. Nearly half of participants
(194/420, 46.2%) felt “very well supported” by their line
manager, although only a quarter (103/420, 24.5%) felt the
same about their department/unit and less for their organ-
isation (67/420, 16.0%). 115/420 (27.4%) participants pro-
vided free-text comments on other areas that they felt
related to career development for trial managers and that
had not been covered by previous questions. The main
themes identified from free-text responses were (1) lack of
recognition, understanding and value of the role of trial
manager, (2) fixed/short-term contracts and funding, (3)
lack of training and clear career pathway, (4) disparity be-
tween organisations and (5) lack of time and capacity to
focus on career development. Comments reflected the
quantitative data and are shown in Table 6.
Discussion
Relevance to trial management professionals within the
UK
Although publications in the past have highlighted the
importance of career development for trial management
professionals, this is the first published survey (to our
knowledge) to demonstrate what is important to trial
management professionals with respect to their own car-
eer development. The views of trial management profes-
sionals are important to consider by organisations
involved in clinical trials when developing any initiatives
to improve the development, retention and remuner-
ation of their staff. Our response rate was consistent
with other surveys in organisational research [8]. Al-
though we recognise that the response rate of 51.3%
could lead to non-response bias, 420 participants were
Table 2 Professional development opportunities
Opportunities that are considered important –
mean (SD)
All Length of time
in a trial
management
role
Salary scale Previous
promotion
Based in a
registered CTU
Academic grade/
pathwayb
<1–5
y
6- >10
y
<£35,
000
>£35,
000
Yes No Yes No Prof Research
n =
420
n =
224
n =
196
n =
162a
n =
242a
n =
224
n =
196
n =
317
n =
103
n =
267
N = 67
To attend relevant training courses 8.3
(1.8)
8.4
(1.8)
8.2
(1.9)
8.4 (1.8) 8.3 (1.8) 8.3
(1.9)
8.4
(1.8)
8.4
(1.8)
8.1
(1.9)
8.3
(1.9)
8.3 (1.8)
To help in the design of trials 7.7
(2.4)
7.5
(2.5)
8.0
(2.2)
7.4 (2.6) 7.9 (2.2) 7.8
(2.3)
7.6
(2.4)
7.8
(2.3)
7.4
(2.6)
7.7
(2.4)
8.2 (1.9)
To undertake qualifications applicable to trial
management
7.5
(2.6)
7.8
(2.5)
7.2
(2.7)
7.9 (2.5) 7.3 (2.5) 7.3
(2.8)
7.8
(2.4)
7.4
(2.7)
7.8
(2.3)
7.5
(2.7)
7.7 (2.2)
To contribute to academic writing and publication 7.3
(2.7)
7.1
(2.7)
7.5
(2.6)
6.9 (2.8) 7.4 (2.6) 7.3
(2.7)
7.3
(2.7)
7.4
(2.6)
6.8
(2.9)
7.2
(2.7)
8.6 (1.7)
To join committees/ groups related to trials 7.0
(2.9)
6.9
(2.5)
7.2
(2.4)
6.8 (2.6) 7.2 (2.3) 7.0
(2.5)
7.1
(2.4)
7.0
(2.4)
7.0
(2.6)
7.0
(2.5)
7.2 (2.1)
To assist with obtaining funding for trials 7.0
(2.5)
6.6
(2.9)
7.4
(2.8)
6.5 (2.8) 7.3 (2.8) 7.3
(2.7)
6.6
(3.0)
7.1
(2.8)
6.5
(3.0)
7.0
(2.9)
7.8 (2.4)
To work on more complex trials 6.5
(2.6)
6.6
(2.5)
6.4
(2.8)
6.5 (2.5) 6.5 (2.5) 6.5
(2.8)
6.6
(2.5)
6.6
(2.6)
6.5
(2.7)
6.5
(2.8)
6.5 (2.3)
To work in a variety of clinical areas 6.4
(2.7)
6.6
(2.5)
6.2
(2.8)
6.9 (2.4) 6.1 (2.8) 6.3
(2.7)
6.6
(2.6)
6.5
(2.7)
6.1
(2.6)
6.4
(2.7)
6.1 (2.9)
To contribute to methodological studies/SWATs 6.1
(3.0)
5.8
(2.9)
6.5
(3.0)
5.9 (3.0) 6.3 (3.0) 6.2
(3.0)
6.0
(3.0)
6.3
(2.9)
5.7
(3.0)
6.3
(3.0)
6.7 (2.7)
To present work at conferences 6.1
(3.0)
6.0
(2.9)
6.1
(3.1)
5.7 (3.1) 6.2 (2.9) 6.2
(2.9)
6.2
(2.9)
6.1
(3.0)
5.9
(3.0)
6.0
(3.0)
7.1 (2.8)
To work on trials outside the UK 5.5
(3.2)
5.4
(3.3)
5.5
(3.2)
5.7 (3.3) 5.3 (3.2) 5.6
(3.2)
5.3
(3.3)
5.5
(3.2)
5.3
(3.4)
5.8
(3.2)
5.0 (3.3)
to work on larger (sites and participants) trials 5.4
(2.9)
5.7
(2.7)
5.1
(3.0)
5.7 (2.8) 5.2 (3.0) 5.3
(3.0)
5.6
(2.8)
5.3
(2.9)
5.7
(3.0)
5.5
(2.9)
5.1 (2.7)
Abbreviations: CTU clinical trials unit, SD standard deviation, SWAT study within a trial
a For salary scale, the 16 respondents who answered “prefer not to say” were not included in this analysis
b For academic grade/pathway, only responses from respondents based in a University are included. Prof = “Professional/Administrative/Managerial/Academic-
related”. Twenty respondents are not included since contract type was unknown
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included in the analyses and, other than a higher re-
sponse from trial management professionals based in
registered CTUs than overall, UKTMN members who
responded to the survey were generally representative of
UKTMN members. Participants had a range of experi-
ence, varying between less than 1 year to more than 10
years, and there was roughly an equal split between par-
ticipants who had experienced a previous promotion to
a more senior role and those who had not (53% vs. 46%),
demonstrating the relevance of these survey results to
trial managers based in the UK. There is clear disparity
between organisations with respect to the job titles of
trial management professionals, which could be a con-
tributing factor to the development of a structured car-
eer pathway. The topic of career development is clearly
important to trial management professionals, as demon-
strated by the fact that almost all (401/420, 95.5%) par-
ticipants rated career development as either ‘very’ or
‘quite’ important to them.
Opportunities for career development of trial
management professionals
Our data have shown that attending relevant training
courses is the most important opportunity for trial man-
agement professionals when they are considering career
development. There were only minor differences in sub-
analyses when considering the associations of length of
time in a trial management role, their salary scale,
whether they had previously been promoted/progressed
or whether they were based in a registered CTU. This
demonstrates a clear opportunity for universities, NHS
trusts and CTUs to ensure adequate investment in train-
ing for trial management professionals in order for them
to manage clinical trials to the high quality required.
Large funders such as the NIHR are offering many train-
ing opportunities through initiatives such as the NIHR
Academy, although almost all are focussed on training
for NHS health professionals [9] rather than operational
staff who coordinate clinical trials located mostly in a
university setting. Some differences were seen between
trial management professionals employed on a research
contract rather than a professional/managerial contract.
Unsurprisingly, those employed on a research contract
considered the most important opportunity to be in-
volved in academic writing (mean score 8.6/10). Attend-
ing conferences was also placed higher in those on a
research contract compared with those on a profes-
sional/managerial contract (7.1/10 vs. 6/10). Both of
these are consistent with common tasks an academic re-
searcher would be involved in, so understandably trial
management professionals employed on a research con-
tract would see merit in having opportunities to develop
in these areas. Participants also rated helping with the
design of trials highly (second most important opportun-
ity for all participants; mean score overall 7.7/10), and
trial management professionals who had been in their
role for more than 6 years scored this slightly higher
than those in the role for less than 5 years. This is
Table 3 Top three perceived enablers of career development
Top three professional development opportunities
1 2 3
All respondents Training Trial design Qualifications
Length of time in a trial management role
<1–5 years Training Qualifications Trial design
6- >10 years Training Trial design Qualifications
Salary scale
<£35,000 Training Qualifications Trial design
>£35,000 Training Trial design Academic writing
Previously promoted
Yes Training Trial design Qualifications, academic writing, assist with funding
No Training Qualifications Trial design
Based in a registered clinical trials unit
Yes Training Trial design Qualifications, academic writing
No Training Qualifications Trial design
Academic grade/pathway
Professional Training Trial design Qualifications
Research Academic writing Training Trial design
Full wording for each opportunity is as follows: “Training” – to attend relevant training courses; “Trial design” – to help in the design of trials; “Qualifications” – to
undertake qualifications applicable to trial management; “Academic writing” – to contribute to academic writing and publications; “Assist with funding” – to assist
with obtaining funding for trials
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Table 6 Themes identified from free-text comments
Theme Example quotes
Lack of recognition, understanding and value of
the role of trial manager
“Trial managers are seen as less important than academics in the university setting”.
“I don’t think trial management is seen as a professional career in the academic community”.
“There is a significant problem with recognising the contribution a trial manager makes to the
team”.
“I was once called a glorified administrator by an academic”.
Fixed/short-term contracts and funding “Short-term funding is the key barrier to career development”.
“Although I work in a large registered CTU, I do not feel that the training is given to support the
move to the next level within the unit”.
Lack of training and clear career pathway “There is no guidance out there about what training would be best for career progression”.
“The role feels very much like a dead-end job with no official training or career pathway”.
“I would like to be able to send the staff on more external development opportunities, but it is
difficult to see where that funding would come from”.
Disparity between organisations “Having worked on trials in different organisations and worked with colleagues who have also
worked on trials in other trials units I think there are discrepancies across the country in terms of
grading of trial manager and senior trial manager positions”.
“Huge disparity between organisations on how the role is treated and valued”.
“Lack of consistency between units - the name of roles is not consistent”.
Lack of time and capacity to focus on career
development
“Your whole time is taken up with the demanding work of keeping your trial running”.
“I think time and money are the biggest factors affecting career development”.
“There is lack of funding to provide time to develop outside the immediate delivery of the trial”.
Abbreviation: CTU clinical trials unit
Table 5 Top three perceived barriers to career development
Top three perceived barriers to career development
1 2 3
All respondents Funding Few opportunities Unclear career pathway
Length of time in a trial management role
<1–5 years Funding Few opportunities Unclear career pathway
6- >10 years Recognition Few opportunities Unclear career pathway
Salary scale
<£35,000 Funding Few opportunities Unclear career pathway, recognition, lack of time
>£35,000 Unclear career pathway Recognition Funding, few opportunities
Previously promoted
Yes Few opportunities Funding, lack of time Recognition
No Unclear career pathway Funding Few opportunities
Based in a registered clinical trials unit
Yes Few opportunities Funding Recognition, lack of time
No Unclear career pathway Funding Recognition
Academic grade/pathway
Professional Funding Few opportunities Recognition
Research Few opportunities, lack of time Recognition, unclear career pathway Funding
Full wording for each barrier is as follows: “Funding” – funding; “Few opportunities” – few opportunities aside managing a trial(s); “unclear career pathway” -
unclear career pathway in organisation; “recognition” – recognition of role; “lack of time” – lack of time
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consistent with the fact that trial management profes-
sionals who are more highly paid also scored the oppor-
tunity to assist with obtaining funding for trials highly
(mean score 7.3/10). This could suggest that the desire to
input into trial design and funding applications comes
with more trial management experience, potentially hav-
ing a deeper understanding of the importance of trial de-
livery and having seen design issues leading to difficulties
with the conduct of the trial further along in the trial life
cycle. This is consistent with a recent commentary by
Kelly et al. [7], who suggest that lead investigators should
invite senior operational staff to be co-applicants on trial
grant applications to prevent such issues from arising. In-
vestigators and academic staff within CTUs should include
experienced trial management professionals in the design
stage of their trials as they can add value and make an im-
portant contribution. In addition, this could facilitate the
career development and job satisfaction of the experienced
trial managers. Participants considered obtaining relevant
qualifications applicable to trial management as important
(all participants mean score 7.5/10, third most important
opportunity) and this was seen as slightly more important
for trial management professionals with less experience (<
1–5 years) (mean score 7.8/10, second highest opportun-
ity) and those based outside of registered CTUs (mean
score 7.8/10, second highest opportunity). Although there
are opportunities to obtain qualifications such as a clinical
trials MSc offered by various universities, the value of such
qualifications is unclear since they do not link to a specific
career pathway. In addition, although employability fol-
lowing completion of one such MSc in clinical trials, at
University College London, has increased and led to pro-
motion (Helen M. Meadows, personal communication), it
can be difficult for trial managers to attend such courses
because of some of the barriers already outlined.
Barriers to career development
Lack of funding and fixed-term contracts were clearly identi-
fied as barriers to career development; 61% of all partici-
pants stated that this was an issue and there was little
difference in perception between trial management profes-
sionals with less or more experience. In an environment
where funding for these types of roles is often project-based
and for a time-limited period, this is difficult, and univer-
sities and NHS organisations should consider how trial
managers may be given the same opportunities as tenured
staff. Participants also identified that they are given few op-
portunities to get involved in activities outside of the day-to-
day running of their clinical trial and this perception was
greater amongst trial management professionals with more
than 6 years’ experience. Investigators and CTUs could con-
sider how trial management professionals work together,
possibly in teams (as is the case in many CTUs), to ensure
adequate and appropriate cover for their clinical trials, whilst
balancing the development needs of individuals to allow
them opportunities to get involved in other activities outside
of their trial (e.g., training, trial design, and funding applica-
tions). It was no surprise to the authors that an unclear car-
eer pathway within an organisation was identified as a
barrier to career development by nearly 60% of participants
(slightly higher for trial management professionals with more
than 6 years’ experience); this reflects an area that the
UKTMN has highlighted since its launch over 20 years ago.
For trial managers based outside of CTUs, this is clearly a
bigger barrier; almost three quarters of participants (74.8%)
stated that this was a barrier, and amongst this sub-group,
this was the number one barrier identified. This is in line
with 56% of participants also identifying that ‘recognition of
the role’ is a barrier to career development and that, whilst
most participants felt supported by their line manager (quite
likely to be someone who works within clinical trials them-
selves), less support at a department and organisational level
was identified. A structured career pathway, where trial man-
agement is recognised as a profession in its own right by
employing organisations and funders, is a long-term vision
of the UKTMN. Within many universities, there are differ-
ences between promotional pathways for staff on research
contracts and staff on professional/administrative contracts.
Trial management professionals, employed on a research
contract, could have the opportunity to apply for promotion
via a standard promotions pathway for research staff. In
order to achieve this promotion, they should be given oppor-
tunities to be involved in academic writing, publishing, and
applying for funding opportunities. However, those
employed on a professional/managerial contract often do
not have the same opportunity and would require their pos-
ition to be re-graded. In universities, staff who are managing
trials should be recognised for their input in the same way
that academic staff are. Our results show that this is even
more important if you are not based within a registered
CTU and may not have this kind of support. As previously
recognised, without a trial manager to manage the day-to-
day activities of a clinical trial, even the best designed trial
could fail [1].
Strengths and limitations
This is the first known study reporting what trial man-
agement professionals consider important with respect
to their career development. The results of the survey
could help facilitate and shape the development of a
standardised career pathway for trial management pro-
fessionals within the UK. It is also hoped that employers,
sponsors and funders give careful thought to a variety of
opportunities that could exist for trial management pro-
fessionals wishing to develop their own careers; these
may well differ depending upon the type of contract the
individual is employed on. By identifying perceived bar-
riers to career development, the organisations involved
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in clinical trials within the UK can see where changes
are required in order to recognise the contribution that
trial management professionals make. In order to design
and deliver high-quality research, it is in the interest of
the clinical trial community that consistency be intro-
duced for trial management professionals. For example,
funding bodies could consider providing funds for train-
ing within grants or bursaries for trial management pro-
fessionals. We recognise that a limitation of this survey
is that only members of the UKTMN were asked to
complete this, thus introducing an element of selection
bias; however, UKTMN members are geographically
spread across the UK, come from a range of UK organi-
sations and therefore are largely representative of trial
management professionals in the UK. The response rate
of 51.3% could have introduced some non-response bias,
although every effort was made to increase the response
rate, including sending several reminders directly to mem-
bers, a social media presence and the incentive of a waived
fee for the 2019 annual meeting upon completion of the
survey, and respondents are representative of the UKTMN
membership. A second limitation is that our survey did
not prevent the possibility of duplicate entries from the
same participant, although we acknowledged this in re-
minders, asking UKTMN members to complete it only if
they had not done so previously. We consider the results
of this survey as relevant to anyone working in clinical tri-
als but also recognise that this is a small step in the wider
national development of a structured pathway. Future re-
search could focus on career development of trial manage-
ment professionals from a multi-stakeholder and
organisational perspective since ultimately a career devel-
opment pathway is a higher strategic development that
would require buy-in from many stakeholders across and
beyond the clinical trials landscape.
Conclusions
Career development is considered important and highly
relevant to trial management professionals. The oppor-
tunities and barriers to career development identified in
the survey could help investigators, organisations, CTUs
and funders facilitate a structured career pathway in the
future. Ensuring that the development needs of trial
management professionals are met is in the interest of
all stakeholders involved in clinical trials since, without
their skills and expertise, high-quality successful clinical
trials will not be delivered effectively.
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